The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the Nuclear Medicine/Radiopharmaceutic market is segmented into
Tc-99
I-123/131
In-111
Xe-133
Th-201
Ga-67
Other
Segment by Application
Diagnostic
Therapeutic
Global Nuclear Medicine/Radiopharmaceutic Market: Regional Analysis
The Nuclear Medicine/Radiopharmaceutic market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Nuclear Medicine/Radiopharmaceutic market report are:
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Global Nuclear Medicine/Radiopharmaceutic Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Nuclear Medicine/Radiopharmaceutic market include:
GE Healthcare
Bracco Imaging
Mallinckrodt
Lantheus Medical Imaging
Bayer
Jubilant Pharma
Nordion
Eli Lilly
SIEMENS
China Isotope & Radiation
Yantai Dongcheng Biochemicals
Table of Contents
1 Nuclear Medicine/Radiopharmaceutic Market Overview
1.1 Product Overview and Scope of Nuclear Medicine/Radiopharmaceutic
1.2 Nuclear Medicine/Radiopharmaceutic Segment by Type
1.2.1 Global Nuclear Medicine/Radiopharmaceutic Sales Growth Rate Comparison by Type (2020-2026)
1.2.2 Tc-99
1.2.3 I-123/131
1.2.4 In-111
1.2.5 Xe-133
1.2.6 Th-201
1.2.7 Ga-67
1.2.8 Other
1.3 Nuclear Medicine/Radiopharmaceutic Segment by Application
1.3.1 Nuclear Medicine/Radiopharmaceutic Sales Comparison by Application: (2020-2026)
1.3.2 Diagnostic
1.3.3 Therapeutic
1.4 Global Nuclear Medicine/Radiopharmaceutic Market Size Estimates and Forecasts
1.4.1 Global Nuclear Medicine/Radiopharmaceutic Revenue 2015-2026
1.4.2 Global Nuclear Medicine/Radiopharmaceutic Sales 2015-2026
1.4.3 Nuclear Medicine/Radiopharmaceutic Market Size by Region: 2020 Versus 2026
2 Global Nuclear Medicine/Radiopharmaceutic Market Competition by Manufacturers
2.1 Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Manufacturers (2015-2020)
2.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Share by Manufacturers (2015-2020)
2.3 Global Nuclear Medicine/Radiopharmaceutic Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Nuclear Medicine/Radiopharmaceutic Manufacturing Sites, Area Served, Product Type
2.5 Nuclear Medicine/Radiopharmaceutic Market Competitive Situation and Trends
2.5.1 Nuclear Medicine/Radiopharmaceutic Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Nuclear Medicine/Radiopharmaceutic Players (Opinion Leaders)
3 Nuclear Medicine/Radiopharmaceutic Retrospective Market Scenario by Region
3.1 Global Nuclear Medicine/Radiopharmaceutic Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Nuclear Medicine/Radiopharmaceutic Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Nuclear Medicine/Radiopharmaceutic Market Facts & Figures by Country
3.3.1 North America Nuclear Medicine/Radiopharmaceutic Sales by Country
3.3.2 North America Nuclear Medicine/Radiopharmaceutic Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Nuclear Medicine/Radiopharmaceutic Market Facts & Figures by Country
3.4.1 Europe Nuclear Medicine/Radiopharmaceutic Sales by Country
3.4.2 Europe Nuclear Medicine/Radiopharmaceutic Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Nuclear Medicine/Radiopharmaceutic Market Facts & Figures by Region
3.5.1 Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales by Region
3.5.2 Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Nuclear Medicine/Radiopharmaceutic Market Facts & Figures by Country
3.6.1 Latin America Nuclear Medicine/Radiopharmaceutic Sales by Country
3.6.2 Latin America Nuclear Medicine/Radiopharmaceutic Sales by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Market Facts & Figures by Country
3.7.1 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales by Country
3.7.2 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Nuclear Medicine/Radiopharmaceutic Historic Market Analysis by Type
4.1 Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2015-2020)
4.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Type (2015-2020)
4.3 Global Nuclear Medicine/Radiopharmaceutic Price Market Share by Type (2015-2020)
4.4 Global Nuclear Medicine/Radiopharmaceutic Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Nuclear Medicine/Radiopharmaceutic Historic Market Analysis by Application
5.1 Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2015-2020)
5.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Application (2015-2020)
5.3 Global Nuclear Medicine/Radiopharmaceutic Price by Application (2015-2020)
6 Company Profiles and Key Figures in Nuclear Medicine/Radiopharmaceutic Business
6.1 GE Healthcare
6.1.1 Corporation Information
6.1.2 GE Healthcare Description, Business Overview
6.1.3 GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2015-2020)
6.1.4 GE Healthcare Products Offered
6.1.5 GE Healthcare Recent Development
6.2 Bracco Imaging
6.2.1 Bracco Imaging Corporation Information
6.2.2 Bracco Imaging Description, Business Overview
6.2.3 Bracco Imaging Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Bracco Imaging Products Offered
6.2.5 Bracco Imaging Recent Development
6.3 Mallinckrodt
6.3.1 Mallinckrodt Corporation Information
6.3.2 Mallinckrodt Description, Business Overview
6.3.3 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Mallinckrodt Products Offered
6.3.5 Mallinckrodt Recent Development
6.4 Lantheus Medical Imaging
6.4.1 Lantheus Medical Imaging Corporation Information
6.4.2 Lantheus Medical Imaging Description, Business Overview
6.4.3 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Lantheus Medical Imaging Products Offered
6.4.5 Lantheus Medical Imaging Recent Development
6.5 Bayer
6.5.1 Bayer Corporation Information
6.5.2 Bayer Description, Business Overview
6.5.3 Bayer Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Bayer Products Offered
6.5.5 Bayer Recent Development
6.6 Jubilant Pharma
6.6.1 Jubilant Pharma Corporation Information
6.6.2 Jubilant Pharma Description, Business Overview
6.6.3 Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Jubilant Pharma Products Offered
6.6.5 Jubilant Pharma Recent Development
6.7 Nordion
6.6.1 Nordion Corporation Information
6.6.2 Nordion Description, Business Overview
6.6.3 Nordion Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Nordion Products Offered
6.7.5 Nordion Recent Development
6.8 Eli Lilly
6.8.1 Eli Lilly Corporation Information
6.8.2 Eli Lilly Description, Business Overview
6.8.3 Eli Lilly Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Eli Lilly Products Offered
6.8.5 Eli Lilly Recent Development
6.9 SIEMENS
6.9.1 SIEMENS Corporation Information
6.9.2 SIEMENS Description, Business Overview
6.9.3 SIEMENS Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2015-2020)
6.9.4 SIEMENS Products Offered
6.9.5 SIEMENS Recent Development
6.10 China Isotope & Radiation
6.10.1 China Isotope & Radiation Corporation Information
6.10.2 China Isotope & Radiation Description, Business Overview
6.10.3 China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2015-2020)
6.10.4 China Isotope & Radiation Products Offered
6.10.5 China Isotope & Radiation Recent Development
6.11 Yantai Dongcheng Biochemicals
6.11.1 Yantai Dongcheng Biochemicals Corporation Information
6.11.2 Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Description, Business Overview
6.11.3 Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Yantai Dongcheng Biochemicals Products Offered
6.11.5 Yantai Dongcheng Biochemicals Recent Development
7 Nuclear Medicine/Radiopharmaceutic Manufacturing Cost Analysis
7.1 Nuclear Medicine/Radiopharmaceutic Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Nuclear Medicine/Radiopharmaceutic
7.4 Nuclear Medicine/Radiopharmaceutic Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Nuclear Medicine/Radiopharmaceutic Distributors List
8.3 Nuclear Medicine/Radiopharmaceutic Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Nuclear Medicine/Radiopharmaceutic Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Nuclear Medicine/Radiopharmaceutic by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Nuclear Medicine/Radiopharmaceutic by Type (2021-2026)
10.2 Nuclear Medicine/Radiopharmaceutic Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Nuclear Medicine/Radiopharmaceutic by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Nuclear Medicine/Radiopharmaceutic by Application (2021-2026)
10.3 Nuclear Medicine/Radiopharmaceutic Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Nuclear Medicine/Radiopharmaceutic by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Nuclear Medicine/Radiopharmaceutic by Region (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) Comparison by Application: 2020 VS 2026
Table 3. Global Nuclear Medicine/Radiopharmaceutic Market Size by Type (Kiloton) (US$ Million) (2020 VS 2026)
Table 4. Global Key Nuclear Medicine/Radiopharmaceutic Manufacturers Covered in This Study
Table 5. Global Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) by Manufacturers (2015-2020)
Table 6. Global Nuclear Medicine/Radiopharmaceutic Sales Share by Manufacturers (2015-2020)
Table 7. Global Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Nuclear Medicine/Radiopharmaceutic Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Nuclear Medicine/Radiopharmaceutic Average Price (US$/Ton) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Nuclear Medicine/Radiopharmaceutic Sales Sites and Area Served
Table 11. Manufacturers Nuclear Medicine/Radiopharmaceutic Product Types
Table 12. Global Nuclear Medicine/Radiopharmaceutic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Nuclear Medicine/Radiopharmaceutic by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Medicine/Radiopharmaceutic as of 2019)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Nuclear Medicine/Radiopharmaceutic Players
Table 16. Global Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) by Region (2015-2020)
Table 17. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Region (2015-2020)
Table 18. Global Nuclear Medicine/Radiopharmaceutic Revenue (Million US$) by Region (2015-2020)
Table 19. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Region (2015-2020)
Table 20. North America Nuclear Medicine/Radiopharmaceutic Sales by Country (2015-2020) (Kiloton)
Table 21. North America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Country (2015-2020)
Table 22. North America Nuclear Medicine/Radiopharmaceutic Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Country (2015-2020)
Table 24. Europe Nuclear Medicine/Radiopharmaceutic Sales by Country (2015-2020) (Kiloton)
Table 25. Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Country (2015-2020)
Table 26. Europe Nuclear Medicine/Radiopharmaceutic Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales by Region (2015-2020) (Kiloton)
Table 29. Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Nuclear Medicine/Radiopharmaceutic Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Region (2015-2020)
Table 32. Latin America Nuclear Medicine/Radiopharmaceutic Sales by Country (2015-2020) (Kiloton)
Table 33. Latin America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Country (2015-2020)
Table 34. Latin America Nuclear Medicine/Radiopharmaceutic Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales by Country (2015-2020) (Kiloton)
Table 37. Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Country (2015-2020)
Table 40. Global Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) by Type (2015-2020)
Table 41. Global Nuclear Medicine/Radiopharmaceutic Sales Share by Type (2015-2020)
Table 42. Global Nuclear Medicine/Radiopharmaceutic Revenue (Million US$) by Type (2015-2020)
Table 43. Global Nuclear Medicine/Radiopharmaceutic Revenue Share by Type (2015-2020)
Table 44. Global Nuclear Medicine/Radiopharmaceutic Price (US$/Ton) by Type (2015-2020)
Table 45. Global Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) by Application (2015-2020)
Table 46. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2015-2020)
Table 47. Global Nuclear Medicine/Radiopharmaceutic Sales Growth Rate by Application (2015-2020)
Table 48. GE Healthcare Corporation Information
Table 49. GE Healthcare Description and Business Overview
Table 50. GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2015-2020)
Table 51. GE Healthcare Main Product
Table 52. GE Healthcare Recent Development
Table 53. Bracco Imaging Corporation Information
Table 54. Bracco Imaging Description and Business Overview
Table 55. Bracco Imaging Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2015-2020)
Table 56. Bracco Imaging Main Product
Table 57. Bracco Imaging Recent Development
Table 58. Mallinckrodt Corporation Information
Table 59. Mallinckrodt Description and Business Overview
Table 60. Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2015-2020)
Table 61. Mallinckrodt Main Product
Table 62. Mallinckrodt Recent Development
Table 63. Lantheus Medical Imaging Corporation Information
Table 64. Lantheus Medical Imaging Description and Business Overview
Table 65. Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2015-2020)
Table 66. Lantheus Medical Imaging Main Product
Table 67. Lantheus Medical Imaging Recent Development
Table 68. Bayer Corporation Information
Table 69. Bayer Description and Business Overview
Table 70. Bayer Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2015-2020)
Table 71. Bayer Main Product
Table 72. Bayer Recent Development
Table 73. Jubilant Pharma Corporation Information
Table 74. Jubilant Pharma Description and Business Overview
Table 75. Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2015-2020)
Table 76. Jubilant Pharma Main Product
Table 77. Jubilant Pharma Recent Development
Table 78. Nordion Corporation Information
Table 79. Nordion Description and Business Overview
Table 80. Nordion Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2015-2020)
Table 81. Nordion Main Product
Table 82. Nordion Recent Development
Table 83. Eli Lilly Corporation Information
Table 84. Eli Lilly Description and Business Overview
Table 85. Eli Lilly Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2015-2020)
Table 86. Eli Lilly Main Product
Table 87. Eli Lilly Recent Development
Table 88. SIEMENS Corporation Information
Table 89. SIEMENS Description and Business Overview
Table 90. SIEMENS Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2015-2020)
Table 91. SIEMENS Main Product
Table 92. SIEMENS Recent Development
Table 93. China Isotope & Radiation Corporation Information
Table 94. China Isotope & Radiation Description and Business Overview
Table 95. China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2015-2020)
Table 96. China Isotope & Radiation Main Product
Table 97. China Isotope & Radiation Recent Development
Table 98. Yantai Dongcheng Biochemicals Corporation Information
Table 99. Yantai Dongcheng Biochemicals Description and Business Overview
Table 100. Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2015-2020)
Table 101. Yantai Dongcheng Biochemicals Main Product
Table 102. Yantai Dongcheng Biochemicals Recent Development
Table 103. Production Base and Market Concentration Rate of Raw Material
Table 104. Key Suppliers of Raw Materials
Table 105. Nuclear Medicine/Radiopharmaceutic Distributors List
Table 106. Nuclear Medicine/Radiopharmaceutic Customers List
Table 107. Nuclear Medicine/Radiopharmaceutic Market Trends
Table 108. Nuclear Medicine/Radiopharmaceutic Opportunities and Drivers
Table 109. Nuclear Medicine/Radiopharmaceutic Market Challenges
Table 110. Global Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) Forecast by Type (2021-2026)
Table 111. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share Forecast by Type (2021-2026)
Table 112. Global Nuclear Medicine/Radiopharmaceutic Revenue (Million US$) Forecast by Type (2021-2026)
Table 113. Global Nuclear Medicine/Radiopharmaceutic Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 114. Global Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) Forecast by Application (2021-2026)
Table 115. Global Nuclear Medicine/Radiopharmaceutic Revenue (Million US$) Forecast by Application (2021-2026)
Table 116. Global Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) Forecast by Region (2021-2026)
Table 117. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share Forecast by Region (2021-2026)
Table 118. Global Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Region (2021-2026) (US$ Million)
Table 119. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share Forecast by Region (2021-2026)
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Nuclear Medicine/Radiopharmaceutic
Figure 2. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type: 2020 VS 2026
Figure 3. Tc-99 Product Picture
Figure 4. I-123/131 Product Picture
Figure 5. In-111 Product Picture
Figure 6. Xe-133 Product Picture
Figure 7. Th-201 Product Picture
Figure 8. Ga-67 Product Picture
Figure 9. Other Product Picture
Figure 10. Global Nuclear Medicine/Radiopharmaceutic Consumption Market Share by Application: 2020 VS 2026
Figure 11. Diagnostic
Figure 12. Therapeutic
Figure 13. Global Nuclear Medicine/Radiopharmaceutic Market Size 2015-2026 (US$ Million)
Figure 14. Global Nuclear Medicine/Radiopharmaceutic Sales Capacity (Kiloton) (2015-2026)
Figure 15. Global Nuclear Medicine/Radiopharmaceutic Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Nuclear Medicine/Radiopharmaceutic Sales Share by Manufacturers in 2020
Figure 17. Global Nuclear Medicine/Radiopharmaceutic Revenue Share by Manufacturers in 2019
Figure 18. The Global 5 and 10 Largest Players: Market Share by Nuclear Medicine/Radiopharmaceutic Revenue in 2019
Figure 19. Nuclear Medicine/Radiopharmaceutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Region (2015-2020)
Figure 21. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Region in 2019
Figure 22. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Region (2015-2020)
Figure 23. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Region in 2019
Figure 24. North America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Country in 2019
Figure 25. North America Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Country in 2019
Figure 26. U.S. Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (Kiloton)
Figure 27. U.S. Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 28. Canada Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (Kiloton)
Figure 29. Canada Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 30. Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Country in 2019
Figure 31. Europe Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Country in 2019
Figure 32. Germany Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (Kiloton)
Figure 33. Germany Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. France Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (Kiloton)
Figure 35. France Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. U.K. Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (Kiloton)
Figure 37. U.K. Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Italy Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (Kiloton)
Figure 39. Italy Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Russia Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (Kiloton)
Figure 41. Russia Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales Market Share by Region in 2019
Figure 43. Asia Pacific Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Region in 2019
Figure 44. China Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (Kiloton)
Figure 45. China Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. Japan Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (Kiloton)
Figure 47. Japan Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. South Korea Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (Kiloton)
Figure 49. South Korea Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. India Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (Kiloton)
Figure 51. India Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Australia Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (Kiloton)
Figure 53. Australia Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Taiwan Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (Kiloton)
Figure 55. Taiwan Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Indonesia Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (Kiloton)
Figure 57. Indonesia Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Thailand Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (Kiloton)
Figure 59. Thailand Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Malaysia Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (Kiloton)
Figure 61. Malaysia Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Philippines Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (Kiloton)
Figure 63. Philippines Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Vietnam Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (Kiloton)
Figure 65. Vietnam Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Latin America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Country in 2019
Figure 67. Latin America Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Country in 2019
Figure 68. Mexico Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (Kiloton)
Figure 69. Mexico Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Brazil Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (Kiloton)
Figure 71. Brazil Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Argentina Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (Kiloton)
Figure 73. Argentina Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales Market Share by Country in 2019
Figure 75. Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Country in 2019
Figure 76. Turkey Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (Kiloton)
Figure 77. Turkey Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Saudi Arabia Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (Kiloton)
Figure 79. Saudi Arabia Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. UAE Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (Kiloton)
Figure 81. UAE Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Sales Market Share of Nuclear Medicine/Radiopharmaceutic by Type (2015-2020)
Figure 83. Sales Market Share of Nuclear Medicine/Radiopharmaceutic by Type in 2020
Figure 84. Global Nuclear Medicine/Radiopharmaceutic Market Share by Price Range (2015-2020)
Figure 85. Revenue Market Share of Nuclear Medicine/Radiopharmaceutic by Type in 2019
Figure 86. Global Nuclear Medicine/Radiopharmaceutic Sales Growth by Type (2015-2020) (Kiloton)
Figure 87. Sales Market Share of Nuclear Medicine/Radiopharmaceutic by Application (2015-2020)
Figure 88. Sales Market Share of Nuclear Medicine/Radiopharmaceutic by Application in 2020
Figure 89. Revenue Share of Nuclear Medicine/Radiopharmaceutic by Application (2015-2020)
Figure 90. Revenue Share of Nuclear Medicine/Radiopharmaceutic by Application in 2020
Figure 91. Key Raw Materials Price Trend
Figure 92. Manufacturing Cost Structure of Nuclear Medicine/Radiopharmaceutic
Figure 93. Manufacturing Process Analysis of Nuclear Medicine/Radiopharmaceutic
Figure 94. Nuclear Medicine/Radiopharmaceutic Industrial Chain Analysis
Figure 95. Channels of Distribution
Figure 96. Distributors Profiles
Figure 97. Porter's Five Forces Analysis
Figure 98. Bottom-up and Top-down Approaches for This Report
Figure 99. Data Triangulation
Figure 100. Key Executives Interviewed
2020 Global Nuclear Medicine/Radiopharmaceutic Market Outlook
Nuclear Medicine,or Radiopharmaceuticals, are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The org... |
Buy Any Report Avail 25% Discount. Coupon Code: JAN25